[
Biochemical recurrence
PSMA PET/CT
PYLCLARI
Piflufolastat
Prostate cancer
[18F]DCFPyL
Journal
European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
18
05
2023
accepted:
05
06
2023
medline:
4
10
2023
pubmed:
21
6
2023
entrez:
21
6
2023
Statut:
ppublish
Résumé
Primary objective was to compare the per-patient detection rates (DR) of [ This was a prospective, open label, cross-over, comparative study with randomized treatment administration of [ A total of 205 patients with first BCR after radical prostatectomy (73%; median PSA = 0.46 ng/ml [CI 0.16;27.0]) or radiation therapy (27%; median PSA = 4.23 ng/ml [CI 1.4;98.6]) underwent [ The primary endpoint of this study was achieved, confirming a significantly higher detection rate for [
Identifiants
pubmed: 37341747
doi: 10.1007/s00259-023-06301-5
pii: 10.1007/s00259-023-06301-5
pmc: PMC10542307
doi:
Substances chimiques
Prostate-Specific Antigen
EC 3.4.21.77
fluoromethylcholine
0
fluorocholine
6029HGL0QP
Types de publication
Randomized Controlled Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3439-3451Informations de copyright
© 2023. The Author(s).
Références
J Urol. 2007 Feb;177(2):540-5
pubmed: 17222629
J Cell Biochem. 2004 Feb 15;91(3):528-39
pubmed: 14755683
Mol Imaging Biol. 2015 Aug;17(4):565-74
pubmed: 25896814
Eur Radiol. 2022 Nov;32(11):7374-7385
pubmed: 35486169
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
Eur Urol. 2018 Aug;74(2):131-133
pubmed: 29625757
Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):965-74
pubmed: 16798415
J Urol. 2004 Sep;172(3):910-4
pubmed: 15310996
Nat Rev Urol. 2017 Jan;14(1):15-25
pubmed: 27725639
J Urol. 2000 Jul;164(1):101-5
pubmed: 10840432
J Nucl Med. 2020 Apr;61(4):546-551
pubmed: 31628216
J Nucl Med. 2022 Oct;63(10):1531-1536
pubmed: 36008118
Mol Imaging Biol. 2016 Jun;18(3):411-9
pubmed: 27080322
Am J Nucl Med Mol Imaging. 2019 Apr 15;9(2):127-139
pubmed: 31139496
J Nucl Med. 2018 Jul;59(7):1076-1080
pubmed: 29269569
J Urol. 2018 Jan;199(1):126-132
pubmed: 28736318
BMC Cancer. 2017 May 22;17(1):361
pubmed: 28532400
J Urol. 2021 Jul;206(1):52-61
pubmed: 33634707
Cancer. 2002 Jul 15;95(2):281-6
pubmed: 12124827
Clin Physiol Funct Imaging. 2017 Oct 29;:
pubmed: 29082604
J Nucl Med. 2023 Mar;64(3):395-401
pubmed: 36265908
Eur Urol. 2021 Feb;79(2):243-262
pubmed: 33172724
Clin Cancer Res. 2021 Jul 1;27(13):3674-3682
pubmed: 33622706
Diagnostics (Basel). 2018 Feb 11;8(1):
pubmed: 29439481
J Nucl Med. 2017 Nov;58(11):1797-1804
pubmed: 28450569
J Nucl Med. 2019 Dec;60(12):1730-1735
pubmed: 31000583
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Eur J Nucl Med Mol Imaging. 2006 Dec;33(12):1387-98
pubmed: 16865395